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Abstract Understanding the fate of exogenous cells after implantation is important for clinical
applications. Preclinical studies allow imaging of cell location and survival. Labelling with
nanoparticles enables high sensitivity detection, but cell division and cell death cause signal dilution
and false positives. By contrast, genetic reporter signals are amplified by cell division. Here, we
characterise lentivirus-based bi-cistronic reporter gene vectors and silica-coated gold nanorods
(GNRs) as synergistic tools for cell labelling and tracking. Co-expression of the bioluminescence
reporter luciferase and the optoacoustic reporter near-infrared fluorescent protein iRFP720
enabled cell tracking over time in mice. Multispectral optoacoustic tomography (MSOT) showed
immediate biodistribution of GNR-labelled cells after intracardiac injection and successive clearance
of GNRs (day 1–15) with high resolution, while optoacoustic iRFP720 detection indicated tumour
growth (day 10–40). This multimodal cell tracking approach could be applied widely for cancer and
regenerative medicine research to monitor short- and long-term biodistribution, tumour formation
and metastasis.
DOI: https://doi.org/10.7554/eLife.33140.001
Introduction
Non-invasive optical imaging methods for preclinical in vivo research include bioluminescence (BLI)
and fluorescence as well as photoacoustic/optoacoustic tomography, a technology that has only
been developed recently (Deliolanis et al., 2014; Wang and Yao, 2016; Weber et al., 2016). These
imaging modalities have enabled great progress in the tracking of labelled cells longitudinally over
time in animal models of disease, which has become especially relevant for cancer research and cell-
based regenerative medicine therapies (de Almeida et al., 2011; James and Gambhir, 2012;
Sharkey et al., 2016). The resolution and sensitivity of optical imaging in animals is limited by auto-
fluorescence, absorption and scattering of excitation and/or emission light, especially in deep tis-
sues. The optimal window for in vivo optical imaging lies in the near infrared (NIR) spectrum (~650–
900 nm), since absorption through the main endogenous chromophores (oxy-haemoglobin, deoxy-
haemoglobin, melanin, water and lipids) are minimal in this spectral range (Weber et al., 2016). For
permanent cell labelling and tracking, genetic modification with reporter genes is the method of
choice, although fluorescent tags and nanoparticles have been developed recently for sensitive
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short-term cell tracking over a period of a few cell divisions (Comenge et al., 2016; Dixon et al.,
2016).
Using luciferase reporter genes, bioluminescence constitutes the most sensitive optical modality
due to its excellent signal-to-noise ratio, as light emission only occurs in the presence of a functional
enzyme and its required co-factors. Firefly, luciferase has become the most widely used reporter as
its substrates, D-luciferin or CycLuc1 (Evans et al., 2014), are very well tolerated by animals and,
compared to other luciferases, its peak light emission at around 562 nm is closest to the infrared
window for in vivo imaging (de Almeida et al., 2011). Although highly sensitive in vivo cell tracking
via bioluminescence imaging of firefly luciferase is well established (de Almeida et al., 2011;
Mezzanotte et al., 2013), this modality provides poor information about the spatial localisation of
cells. Fluorescence has recently gained importance for animal imaging, since novel near-infrared
fluorescent proteins (iRFPs) were developed from bacterial phytochrome photoreceptors
(Shcherbakova et al., 2015; Shcherbakova and Verkhusha, 2013). Similar to bioluminescence
imaging, fluorescence only allows limited spatial resolution due to the high scattering coefficient of
photons in tissues.
On the other hand, photoacoustic imaging is based on the generation of ultrasound waves after
absorption of light emitted by a pulsed laser. The sound waves are well transmitted in fluid media
and less prone to scattering through tissues than emitted light. In fact, acoustic scattering is three
orders of magnitude less than photon scattering (Wang and Hu, 2012), which overcomes deep tis-
sue spatial resolution drawbacks of other optical-based imaging technologies. Interestingly, some
iRFPs, such as iRFP720, have an absorption profile in the NIR window, thus enabling their use as
reporter genes for photoacoustic imaging, and allowing deep tissue imaging and tumour monitoring
in mice (Deliolanis et al., 2014; Jiguet-Jiglaire et al., 2014). For example, new iRFPs have been
proven to be useful genetic photoacoustic reporters in mammary gland and brain tumour monitor-
ing, which establishes them as dual-modality imaging probes (Deliolanis et al., 2014; Filonov et al.,
eLife digest Many scientists are studying the possibility of using human cells to treat diseases.
For example, using stem cells to regenerate damaged body parts or genetically engineered immune
cells to destroy cancer. Scientists need new tools to track what happens to these cells once they
have been injected into a laboratory animal. This will help them understand how they work and
make sure these potential treatments are safe. One concern with using cells as a treatment is that
they might form cancerous tumors.
To track these cells in a laboratory animal, scientists need two things: a way to distinguish the
treatment cells from the animal’s normal cells and an imaging tool that allows them to see where the
cells are in a living animal. One way to differentiate treatment cells from normal cells is to genetically
engineer them to make a fluorescent protein called iRFP720. Another way is to fill the cells with gold
nanorods. Both, the fluorescent protein and the gold nanorods, absorb light in the infrared range.
Scientists can use a technique called multispectral optoacoustic tomography, which transforms
infrared light into ultrasound signals to create an image, to see where these markers are in the body.
Now, Comenge et al. showed that the gold nanorods and multispectral optoacoustic
tomography track the cells immediately after injection into the blood stream of a mouse. Most of
the injected cells die within a few days, and the nanorods are progressively eliminated from the
body through the liver. But some of the injected cells live on, multiply, and form tumors within a
month. This was expected because the cells they used were chosen for their ability to sometimes
form tumors. Using multispectral optoacoustic tomography to track the cells making iRFP720,
Comenge et al. were able to see exactly where the tumors are deep inside the body.
Together, gold nanorods and iRFP720 could allow scientists to track where the cell-based
therapies for cancer or other diseases go in the short and long term. This may help them prove
whether these treatments work, and whether they have harmful effects. Comenge et al. are helping
other scientists to use these techniques by distributing their tool for making iRFP720-producing
cells.
DOI: https://doi.org/10.7554/eLife.33140.002
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2012; Krumholz et al., 2014). In addition, in multispectral optoacoustic tomography (MSOT), a
rapid multiwavelength excitation allows the distinction between different absorbers simultaneously
after applying multispectral unmixing algorithms (Tzoumas et al., 2014). Hence, a number of endog-
enous (e.g. deoxy- and oxyhaemoglobin) or exogenously introduced targets can be imaged in vivo
via MSOT, including fluorescent proteins and nanoparticles.
Since light absorption triggers the photoacoustic response, contrast agents with a high molar
extinction coefficient facilitate their distinction from endogenous chromophores (Lemaster and Jok-
erst, 2017). In this regard, GNRs are an attractive choice since the extinction coefficients are in the
range of 4–5.5  109 M 1cm 1 for longitudinal surface plasmon between 728 and 845 nm
(Orendorff and Murphy, 2006), that is orders of magnitude higher than endogenous absorbers or
other types of contrast agents (e.g. AlexaFluor750 and iRFP720 coefficients are 2.5  105 and 9.6 
104 M 1cm 1, respectively [Shcherbakova and Verkhusha, 2013; Ntziachristos and Razansky,
2010]). We recently demonstrated how, after coating GNRs with a 35 nm silica shell, the optical
properties of GNRs are maintained even in harsh environments such as the endosomal vesicles
(Comenge et al., 2016). This enabled very sensitive photoacoustic imaging of labelled cells, pushing
the limits of detection into a range useful for biologically-relevant applications including cell tracking
(Wang and Jokerst, 2016). However, cell division and cell death result in a decrease of GNR con-
centration and therefore a decrease of photoacoustic intensity. Thus, for long-term photoacoustic
tracking of cells, adequate reporter genes are required.
Here, we characterise newly generated lentivirus-based bi-cistronic reporter gene vectors and sil-
ica-coated GNRs as synergistic tools for co-labelling of cells and tracking in multiple imaging modali-
ties at different stages after cell administration. The GNR-860 offered an excellent photoacoustic
sensitivity that enabled detection of a very low number of cells. Reporter gene vectors mediated co-
expression of the most sensitive bioluminescent reporter, firefly luciferase, and the most red-shifted
near-infrared fluorescent protein, iRFP720, which also acted as a photoacoustic reporter in MSOT.
Whilst GNR-860 enabled early detection of cells by photoacoustic tomography after systemic injec-
tion, reporter genes were needed to monitor any potential tumour growth with the same technique.
In addition, co-expression of luciferase allowed bioluminescence imaging. Although this modality
does not offer the spatial resolution of photoacoustic tomography, it was used here to continuously
monitor cell viability as well as for validating the photoacoustic results. The combination of the two
cell labelling strategies (nanoparticles and genetic labelling) allowed short-term and long-term multi-
modal imaging of deep tissues with high spatial resolution without compromising sensitivity. It
enabled the non-invasive monitoring of the initial cell biodistribution on a sub-organ level as well as
the detection of tumour formation from very early stages, thus opening opportunities for gaining a
better understanding of the safety of stem cell therapies, which is required for moving towards clini-
cal translation (Ankrum and Karp, 2010).
Results and discussion
Gold nanorod synthesis and cell labelling
Two types of GNRs with distinct optical spectra were prepared following previously published proto-
cols (Nikoobakht and El-Sayed, 2003; Ye et al., 2012). The rationale for evaluating two types of
gold nanorods in this study is as follows. First, detection of GNRs at different wavelengths would
support the versatility of the approach, for example when combining them with other reporter mole-
cules, that is it is not dependent upon preparing the exact same nanorods as reported here. Second,
having two different probes provided us with a powerful control for false positive signals as
explained in more detail below in the context of Figure 4. The first batch consisted of GNRs with a
longitudinal surface plasmon resonance (LSPR) peak at 710 nm (GNR-710). Their core size was
60.0 ± 7.5 nm by 25.7 ± 3.7 nm with an average aspect ratio of 2.3 ± 0.3. The second batch had a
LSPR peak at 860 nm (GNR-860). In this case, their size was 93.8 ± 9.3 nm by 25.2 ± 4.4 nm with an
average aspect ratio of 3.8 ± 0.5) (Figure 1a). Both GNRs were prepared to have LSPR bands in the
NIR to favour their detection deep inside tissues.
We have recently demonstrated that a 35 nm silica shell is needed to minimise plasmon coupling
between GNRs after cell uptake (Comenge et al., 2016). This enables the preservation of intrinsic
optical properties resulting in an increased sensitivity for photoacoustic detection. Hence, both GNR
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batches were coated with a silica shell as previously described (Comenge et al., 2016). Specifically,
GNR-710 and GNRs-860 nm have a silica shell thickness of 38.7 ± 1.9 nm and 35.7 ± 1.6 nm, respec-
tively (Figure 1a).
A murine MSC line was selected for labelling and tracking, since these cells have the capability to
differentiate into mesenchymal derivatives, but can also form tumours occasionally (Comenge et al.,
2016; Kuzma-Kuzniarska et al., 2012). The cells, which had first been transfected with a reporter
gene vector (see below), were incubated with different concentrations of GNR-710 and GNR-860 for
24 hr. To provide a better comparison between GNRs of different sizes, we standardize and report
the GNR concentrations by the optical density (O.D.) of the peak, because absorption is what trig-
gers the photoacoustic response. For reference, O.D. = 4 corresponds to ~100 pM GNR-710
Figure 1. GNR characterization and cell labelling. (a) Representative transmission electron microscopy (TEM) pictures of GNR-710 (top) and GNR-860
(bottom). (b) TEM pictures of GNR-710 (top panels) and GNR-860 (bottom panels) inside cells. In both cases, the silica shell provides steric hindrance to
minimise plasmon coupling in cellular vesicles. (c) Vis-NIR spectrum of GNRs in solution. (d) Vis-NIR spectrum of cells labelled with the corresponding
GNRs. Dashed lines correspond to GNRs in solution. (e) Cell viability at different optical densities. Viability was assessed in triplicate and results are
given as %±SD relative to cells that were cultured without GNRs.
DOI: https://doi.org/10.7554/eLife.33140.003
The following figure supplement is available for figure 1:
Figure supplement 1. Additional images of GNR-710 and GNR-860 uptake by MSCs.
DOI: https://doi.org/10.7554/eLife.33140.004
Comenge et al. eLife 2018;7:e33140. DOI: https://doi.org/10.7554/eLife.33140 4 of 22
Tools and resources Cancer Biology Stem Cells and Regenerative Medicine
and ~72.5 pM GNR-860 (calculated by relating the absorbance at 400 nm of GNRs before silica coat-
ing to concentrations of molecular gold) (Pastoriza-Santos and Liz-Marza´n, 2013).
To characterize their uptake, cells were incubated with GNRs at 0.D. = 3 for 24 hr. TEM images
of cells show GNRs localised inside vesicles, with silica shells separating the gold cores (Figure 1b,
and Figure 1—figure supplement 1). In line with our previous report, the optical properties of
GNRs were largely preserved after cell uptake (Figure 1c,d). Preservation of the absorbance inten-
sity and the shape of the plasmon band are prerequisite for an optimal photoacoustic detection of
GNR-labelled cells since it relies on a spectral deconvolution to differentiate intrinsic absorbers from
probes.
To confirm that the cell labelling does not cause any toxicity, cell viability after exposure to a
range of GNR concentrations up to O.D. = 4 was assessed (Figure 1e). Only at the highest GNR
concentration was a slight decrease in cell viability observed: 92.0 ± 2.6% and 91.7 ± 1.6% for GNR-
710 and GNR-860, respectively. These results are in agreement with our previous work, in which we
showed that silica-coated GNRs did not affect cell viability, proliferation or differentiation potential
of the mMSCs (Comenge et al., 2016).
Generation of iRFP720-Luciferase bi-cistronic lentivirus reporter gene
vectors and characterisation of labelled cells
To combine the sensitivity of bioluminescence imaging with the spatial resolution of MSOT, we gen-
erated bi-cistronic lentivirus vectors for expression of firefly luciferase and iRFP720 from the general
eukaryotic EF1a promoter (Figure 2a). We compared vectors containing either an internal ribosome
entry site (IRES) (Hellen and Sarnow, 2001) or a self-cleaving 2A element (Szymczak and Vignali,
2005; Szymczak et al., 2004), to determine the most efficient method of translating the second
open reading frame (ORF; encoding luciferase) from a single mRNA. Following transfection with len-
tivirus vectors, the mMSCs were selected by FACS for iRFP720 fluorescence, to obtain a pure IRES-
vector and a pure E2A-vector transfected cell population, respectively, with similar levels of expres-
sion of the first ORF protein (iRFP720) (Figure 2b). Co-expression of iRFP720 and luciferase in indi-
vidual cells was confirmed by immunocytochemistry (Figure 2c), which also indicated that, in
contrast to luciferase, iRFP720 was preferentially localised in the nucleus. To compare the levels of
expression of luciferase from the IRES-vector and E2A-vector transfected cells, fluorescent and biolu-
minescent signals were quantified in cell suspensions using an IVIS Spectrum imager. For both types
of reporter cells (IRES-vector and E2A-vector transfected), the fluorescence signal intensity for
iRFP720 was the same, but the E2A-vector-transfected cells showed a five times higher luciferase
bioluminescence (Figure 2d,e). These data indicate that in the context of our bi-cistronic lentivirus
vectors, a superior translation efficiency of the second ORF from a single mRNA was achieved via an
E2A element as compared to an IRES element. We therefore used the pHIV-iRFP720-E2A-Luc vector
in all further experiments described herein. Proof of principle of the application of this vector for
multi-modal imaging was tested in preliminary experiments, in which cells were injected subcutane-
ously and monitored with bioluminescence, fluorescence and photoacoustic imaging (Figure 2—fig-
ure supplement 1).
Imaging biodistribution of cells after intracardiac injection
Detection of labelled cells after subcutaneous injection has provided indications that gold nanorods
(our previous work [Comenge et al., 2016]) and genetic reporters (Figure 2—figure supplement 1)
could enable cell tracking. Similar proof of principle of the utility of nanoparticles as contrast agents
for photoacoustic cell detection has often been obtained by imaging labelled cells implanted locally
(Jokerst et al., 2012; Nam et al., 2012). Here, we address the much more challenging case of a sys-
temic injection where cells spread through the body and the signal, therefore, becomes diluted.
Specifically, 1.5  106 mMSCs transduced with the iRFP720-E2A-Luc lentivirus and labelled with
GNRs were administered via ultrasound-guided intracardiac injection into the left ventricle. Left ven-
tricle administration was chosen for cells to enter the arterial circulation rather than the venous. This
allows cells to pass through all organs before returning to the right ventricle and subsequently lungs,
where they become sequestered in the pulmonary microvasculature (Kean et al., 2013;
Fischer et al., 2009). To provide a detailed assessment of cell localisation, we combined photoa-
coustic tomography imaging at 1 mm steps with bioluminescence detection. While bioluminescence
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imaging provides excellent sensitivity, its anatomical resolution is poor, mainly due to the high
Figure 2. Characterisation of iRFP720-Luciferase bi-cistronic lentivirus reporter gene vectors and transfected cells in vitro. (a) Scheme of the vectors that
mediate co-expression of iRFP720 and firefly luciferase either via IRES- or E2A-mediated mechanisms (not drawn to scale). Arrows above and below the
scheme indicate the reporter gene transcript and open reading frames, respectively. (b) FACS analyses of iRFP720 fluorescent signal intensity in purified
mMSC populations, which had been transfected with either the IRES or E2A vector, respectively, indicated similar levels of expression of the first ORF.
(c) Confocal fluorescence microscopy of transfected cells for co-expression of iRFP720 and luciferase (immunofluorescence). In contrast to Luc, iRFP720
tends to accumulate in the nucleus (yellow triangles). (D, E) COMPARISON OF FLUORESCENT AND BIOLUMINESCENT SIGNAL INTENSITIES FROM IRES AND E2A VECTOR-
TRANSFECTED CELL POPULATIONS USING IVIS SPECTRUM IMAGING. ALTHOUGH BOTH CELL SUSPENSIONS PROVIDED VERY SIMILAR LEVELS OF FLUORESCENCE FROM THE FIRST REPORTER
ORF (IRFP720) IN THE REGION OF INTEREST (ROI), BIOLUMINESCENCE LEVELS WERE 5-FOLD HIGHER IN THE E2A VECTOR-TRANSFECTED CELL POPULATION, INDICATING A MORE
EFFICIENT TRANSLATION OF THE SECOND ORF (LUCIFERASE) FROM THE E2A ELEMENT THAN FROM THE IRES. FLUORESCENCE WAS MEASURED FIRST, FOLLOWED BY ADDITION OF
CYCLUC1 TO THE SAME CELL SUSPENSIONS AND BIOLUMINESCENCE IMAGING.
DOI: https://doi.org/10.7554/eLife.33140.005
The following figure supplement is available for figure 2:
Figure supplement 1. Longitudinal multi-modal imaging of iRFP720-E2A-Luc labelled cells after subcutaneous injection of mMSCs shows
proportionality of bioluminescent, fluorescent and photoacoustic signals of the reporter genes.
DOI: https://doi.org/10.7554/eLife.33140.006
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scattering of photons by tissue (Patterson et al., 1989; Ntziachristos et al., 2005). By contrast,
photoacoustic imaging provides superior spatial resolution (150 mm in our system)
(Ntziachristos and Razansky, 2010). To demonstrate the potential of this multimodal approach to
precisely determine the localisation of distributed nanorod-labelled cells, we show the correlation
between bioluminescence imaging and MSOT imaging (Figure 3). Cell localisation in the head, liver
and kidney regions was clearly observed with both imaging modalities (Figure 3a,b), and the cell
presence within organs was confirmed in the photoacoustic scans through the respective regions
(Figure 3c). This distribution is in agreement with other, different types of assessments in previous
reports (Basse et al., 1988). The presence of cells in the brain region is probably due to cell trap-
ping in small capillaries, as reported also in other studies after intracardiac injection of cells
(Heyn et al., 2006). As shown in our parallel work (Scarfe et al., 2017), the mMSCs remain in the
lumen of the brain capillaries and do not cross the blood-brain barrier. It should be noted here that
there was no difference in the bioluminescence signal biodistribution when cells with or without gold
nanorods were injected, indicating that GNR uptake does not affect the overall behaviour of the
cells (Figure 3—figure supplement 1).
To further test the robustness and specificity of the signal, additional controls were performed.
First, following the same imaging protocols, we observed a similar biodistribution pattern for mice
injected with either GNR-710 or GNR-860-labelled cells (Figure 3—figure supplement 1, and Fig-
ure 3—figure supplement 2). Second, when we applied the unmixing algorithm with the ‘wrong’
spectrum (i.e. the GNR-710 spectrum to an animal injected with GNR-860-labelled cells, and vice
versa), no GNR-specific signals were detected in photoacoustic images pre- and post-injection (Fig-
ure 4). Third, when the photoacoustic spectra of regions of interest before and after injection of cells
were extracted, an increase in the photoacoustic intensity was only observed in the range of wave-
lengths in which corresponding GNRs have the higher absorbance, while intensity in the other wave-
lengths remained similar (Figure 4—figure supplement 1). It has to be noted that in some cases
there were regions with an endogenous absorbance similar to GNRs (e.g. food in the intestines has
similar spectra as GNR-710), which can lead to misinterpretation (Figure 3—figure supplement 2).
For this reason, a scan was performed before cells were injected, which allowed detection of any
potential endogenous interference with the GNR signal. Using a multimodal imaging approach (in
this case luminescence and photoacoustic) also assisted in discounting any false positive signals. As
expected, the photoacoustic signal provided by iRFP720 expression was not strong enough to
detect the cells immediately after injection by means of photoacoustic imaging (Figure 4).
Clearance and fate of the cells and GNRs after initial biodistribution
One day after GNR-labelled cell infusion, only between 15–22% of the initial bioluminescence signal
in whole mice persisted (Figure 5b), decreasing to less than 4% by day 5. Such substantial amounts
of cell death following cell infusion were expected from previous reports (To¨gel et al., 2008;
Bentzon et al., 2005). A similar degree of cell death was observed with cells not labelled with
GNRs, indicating that cell loss in vivo was not caused by GNR labelling (Figure 5—source data 1).
Interestingly, after 24 hr, the bioluminescence signal and the photoacoustic signal for GNRs were no
longer localised in the same regions/organs (Figure 5a–c), indicating that the vast majority of GNRs
followed a different fate than the remaining luciferase-expressing cells. Specifically, although the
luminescence intensity had decreased substantially by 24 hr, the distribution of the signal remained
the same (Figure 5b). By contrast, the MSOT signal for GNR-860 increased dramatically in the liver
over the same timescale, but was substantially reduced in regions such as the kidneys and head
where it had been predominant immediately after cell injection (Figure 5a,c). Whilst luminescent sig-
nal is based on living cells, photoacoustic signal can be produced from GNRs independently, irre-
spective of whether they are within cells, or if the cells are viable. Thus, these data suggest that the
liver plays an important role in the clearance of GNRs and potentially associated cell debris following
the massive loss of cells during the first 24 hr after injection, as previously reported
(Eggenhofer et al., 2012; Khabbal et al., 2015). In addition, these findings are in line with reports
describing nanoparticle clearance through the hepato-biliary tract (Longmire et al., 2008;
Hirn et al., 2011; Lankveld et al., 2011). We observed that the clearance could be continuously
monitored in a longitudinal fashion since the photoacoustic signal in the liver dropped by 47% after
5 days and by 73% after 25 days (Figure 5d).
Comenge et al. eLife 2018;7:e33140. DOI: https://doi.org/10.7554/eLife.33140 7 of 22
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Figure 3. Initial biodistribution of GNR-860-labelled cells after intracardiac administration. (a) Bioluminescence imaging in dorsal (top panel) and ventral
(bottom panel) position after cell administration. Mirrors were placed on the side of the mouse to provide a lateral view. (b) MSOT imaging of the same
animal: 3D reconstruction for the whole animal showed the correlation between GNR-860 signal with bioluminescence imaging (360˚ animation
available in Figure 3—video 1). (c) Cross sections corresponding to the planes shown in (b) before and after the injection of cells. Sub-organ
Figure 3 continued on next page
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Tumour monitoring
Following the substantial loss in cell viability over the first 24 hr, signal intensity declined further and
by day 5 cells were no longer detectable by BLI in the regions where they had first accumulated (i.e.
brain, kidneys and spinal cord, Figure 3). However, we now observed BLI signals from cells that had
settled in different locations (Figure 6—figure supplement 1). The signal intensity increased over
the following weeks as cells grew into tumours (Figure 6—figure supplement 1). Since the mMSC
cell line had been reported to form osteoid structures in vivo (Kuzma-Kuzniarska et al., 2012), and
recent results from our group have revealed the capacity of the cells to form osteosarcomas
(Scarfe et al., 2017), we anticipated the possibility of tumour development. In other studies, this
process has been typically monitored by bioluminescence imaging (Jenkins et al., 2005), which
allows the intensity of the signal to be correlated with the number of living cells. However, biolumi-
nescence is limited by the poor spatial resolution at depths beyond 1 mm due to photon scattering.
We therefore evaluated the potential of MSOT to determine the precise localisation of internal
tumours as well as their size and shape. We used the constitutive expression of iRFP720 for the
long-term monitoring of tumour growth by means of photoacoustic imaging. Presence of iRFP720
resulted in a change of the photoacoustic spectra in the regions where cells were forming tumours
(Figure 6, and Figure 6—figure supplement 2). The fact that the iRFP720 absorption spectrum is
very different from the main endogenous absorbers (a sharp band peaking at 690–700 nm, Fig-
ure 6—figure supplement 2) facilitated its detection even with minimal changes of photoacoustic
intensity compared to the background.
Mice developed tumours in different locations whether the cells were labelled with GNRs or not
(Figure 6 without GNRs and Figure 8 with GNRs). This process could be monitored longitudinally by
bioluminescence and MSOT as shown in Figure 6, where a number of tumours formed in a mouse
30 days after administration of cells labelled with the iRFP720-Luciferase vector. After scanning the
animal in 1 mm steps, multispectral processing of the corresponding cross sections (Figure 6b)
revealed the presence of tumours on the right shoulder (1), spinal cord (2), in the region dorsal of
the kidney (2a and 2b), back (3), hip (4 and 5), and right leg (6). Tumours 2a and 2b are very illustra-
tive of the outcomes that can be achieved with this approach. From the in vivo bioluminescence
images (Figure 6a), it is difficult to determine the localisation of the tumours as either subcutaneous
or in deep tissues, and with which organs they are associated. Analysis of photoacoustic images
revealed that those tumours were growing in an unusual position close to and dorsal of the kidneys
(Figure 6b). Ex vivo luminescence imaging confirmed the observations made with in vivo photoa-
coustic tomography (e.g. tumour masses 2a and 2b were found attached to the anterior-dorsal part
of the kidneys) (Figure 6c). Expression of iRFP720 was also confirmed by ex vivo fluorescence imag-
ing of these tumours (Figure 6—figure supplement 3).
In addition to improving the anatomical localisation of internal tumours, photoacoustic tomography
using iRFP720 expression also allowed precise longitudinal monitoring of tumour development from
very early stages. The example in Figure 7 shows the growth of tumour 4 (Figure 6) from day 13 to
day 30 after cell injection. The excellent spatial resolution enabled the localisation of this tumour in the
vicinity of the pelvic ilium from day 13. The tumour mean diameter at this stage was 1.2 mm. By day
19, 23 and 30 it had expanded to 2.0, 2.2 and 3.3 mm, respectively. Furthermore, changes in the shape
Figure 3 continued
localisation of cells can be observed here (see main text for details and source data at Zenodo (https://zenodo.org/record/1021607) (doi: 10.5281/
zenodo.1021607) for the whole set of cross section images). The brain, liver and kidney are outlined. Colour scales are 3.0  105 to 1.8  106 radiance
units (r  s 1  cm 2  sr 1) in (a) and 0.9 to 21 MSOT intensity (a.u.) in (b) and (c).
DOI: https://doi.org/10.7554/eLife.33140.007
The following video and figure supplements are available for figure 3:
Figure supplement 1. Biodistribution of cells not labelled with GNRs and cells labelled with GNR-710 and GNR-860, respectively, after intracardiac
administration.
DOI: https://doi.org/10.7554/eLife.33140.008
Figure supplement 2. MSOT imaging of cell biodistribution of GNR-710 labelled cells – comparison before and after cell injection.
DOI: https://doi.org/10.7554/eLife.33140.009
Figure 3—video 1. 360˚ animation of the 3D reconstruction shown in Figure 3 of the main text.
DOI: https://doi.org/10.7554/eLife.33140.010
Comenge et al. eLife 2018;7:e33140. DOI: https://doi.org/10.7554/eLife.33140 9 of 22
Tools and resources Cancer Biology Stem Cells and Regenerative Medicine
of the tumour were also monitored from day 23 onwards when it branched off into two ramifications,
which grew attached to the main part of the tumour (Figure 7 and Figure 7—video 1).
In a second example, the presence of several tumours was determined 40 days after injection of
GNR-860 and reporter gene-labelled cells (Figure 8). Although GNRs were not used as contrast
agents for tumour imaging, since the vast majority of them were cleared out following cell death,
tumour growth was monitored with high spatial resolution via iRFP720 expression. The mouse shown
in Figure 8 developed tumours in both shoulders, in the right dorsal kidney/adrenal gland region,
towards the liver, and in several positions of the hip region. A late developing (days 33–40), but fast-
growing tumour in the left shoulder was used to demonstrate the capabilities of iRFP720 MSOT
imaging to obtain detailed spatial information in 3D reconstructions as shown in Figure 8c.
Figure 4. Specificity of the multispectral unmixing. Signal before and after treatment with GNR-710-labelled cells
(upper panel) and GNR-860-labelled cells (bottom panel) in transverse sections at the level of the kidney region of
the corresponding mouse. Signals were observed in the kidney only when the spectra of the respective
component (GNR-710 in upper panel and GNR-860 in bottom panel) was applied. Note also that iRFP720
unmixing did not result in a signal at this stage. Colour scales are 0.1 to 14, 0.9 to 21, and 0.0 to 15 MSOT intensity
(a.u.) for GNR-710, GNR-860, and iRFP720, respectively.
DOI: https://doi.org/10.7554/eLife.33140.011
The following figure supplement is available for figure 4:
Figure supplement 1. Photoacoustic spectra extracted from in vivo imaging.
DOI: https://doi.org/10.7554/eLife.33140.012
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Overall, our analysis reveals that MSOT provides an excellent method to monitor tumour growth
longitudinally from very early stages onwards (from sub mm size). Only some tumours growing in
very peripheral positions of the animal could not be monitored due to technical or procedural limita-
tions of the MSOT imaging system. For example, the nose could not be imaged as it was placed in
the nose cone for air and anaesthesia supply during the imaging process. Also, since the animal was
placed on its back, it was very difficult to avoid an air layer being trapped between the legs and the
main body, which impaired sound propagation. Abundant use of ultrasound gel in this region mini-
mised this effect and allowed data to be obtained as shown in Figure 6 (tumour 6), although the
quality of the image was not as good as in other regions of the body. Any tumours in the lungs could
not have been monitored with photoacoustic imaging due to a different sound propagation in air.
However, the presence of tumours in the lungs could be ruled out from the bioluminescence
images.
Figure 5. Cell death and clearance of GNR-860 from day one after injection. (a) MSOT signal in kidneys disappeared almost completely at day 1. (b)
Total bioluminescence decreased by 78% at day one indicating a large amount of cell death. (c) In contrast to the kidneys, MSOT signal in the liver
increased substantially at day 1, although bioluminescence had declined in this tissue at this stage as shown in (b), which suggests that GNRs
accumulated in the liver. (d) After day 1, MSOT signal in liver decreased progressively. Colour scales in (a) and (c) are 0.5 to 8 MSOT intensity (a.u.).
Colour scale in (b) is 7.0  104 to 5.8  105 radiance units (r  s 1  cm 2  sr 1).
DOI: https://doi.org/10.7554/eLife.33140.013
The following source data is available for figure 5:
Source data 1. Loss in BLI signal intensity within 24 hr after injection.
DOI: https://doi.org/10.7554/eLife.33140.014
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Conclusions
We demonstrate here a multimodal imaging approach, which utilises a combination of GNRs and
reporter genes to track cells immediately after systemic injection and longitudinally over time during
Figure 6. Localisation of tumours 30 days after injection of cells. (a) Bioluminescence images showing different
tumours spread along the mouse body. Dashed lines indicate the approximate region shown in the MSOT scans.
(b) Corresponding MSOT transverse sections showing the precise localisation of different tumours after applying
the multispectral processing for iRFP720. (c) Ex vivo bioluminescence imaging confirmed the localisation of
relevant tumours imaged with MSOT. (d) Ex vivo picture of the tumours shown in (c) with a detail of kidneys in the
inset. (e) Orthoslice images of tumour 2b in (b). Frontal view (left) and tilted view (right) provide a better spatial
visualisation of the tumour´s precise localisation, extending anterior from the dorsal part of the right kidney.
Colour scales are 1.4  108 to 8.5  108 radiance units (r  s 1  cm 2  sr 1) in (a) and 2.6  108 to 5.3  109
radiance units in (c). Colour scale in (b) is 0.4 to 15 MSOT intensity units (a.u.).
DOI: https://doi.org/10.7554/eLife.33140.015
The following figure supplements are available for figure 6:
Figure supplement 1. Bioluminescence monitoring of tumour growth of the mouse shown in Figures 6 and 7 of
the main text.
DOI: https://doi.org/10.7554/eLife.33140.016
Figure supplement 2. In vivo photoacoustic spectra of tumour 2b in Figure 6 of the main text.
DOI: https://doi.org/10.7554/eLife.33140.017
Figure supplement 3. Ex vivo epi-fluorescence image (Ex = 675 nm, Em = 720 nm) of tumours shown in Figure 6,
after fixation with 4% PFA for 24 hr.
DOI: https://doi.org/10.7554/eLife.33140.018
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the development of tumours. We show that multispectral optoacoustic tomography achieves high
spatial resolution of the initial cell distribution through analysis of the GNR signal. Whilst expression
of iRFP720 is initially undetectable, due to the scattered distribution of cells, it provides long-term
tumour monitoring capability in MSOT as clustered iRFP720-positive cells lead to a stronger photoa-
coustic signal. Additionally, bioluminescence imaging of luciferase allowed for the most sensitive
detection of live cells for comparison and validation of the MSOT results.
The silica-coated GNRs provided the excellent photoacoustic sensitivity required to monitor the
broad distribution of labelled cells shortly after systemic intra-cardiac injection. Because the GNRs
maintained their optical signature when taken up by the cells, spectral unmixing could be applied in
MSOT, which allowed GNR signals to be distinguished from other reporters (e.g. iRFP720) and
endogenous absorbers, resulting in highly specific cell detection. Over the medium term, that is sev-
eral days post-injection, photoacoustic GNR signals and luciferase bioluminescence signals became
separated, indicating nanoparticle clearance and surviving cells, respectively. The GNR signal
became localised to the liver, which is in line with the known clearance pathway of nanoparticles and
associated cell debris through the hepato-biliary system.
Using the genetic reporters, longitudinal monitoring of surviving cells and tumour formation was
achieved via luciferase bioluminescence and iRFP720 photoacoustic tomography. Compared to
other optical-based imaging technologies, the superior deep-tissue spatial resolution of MSOT pro-
vided precise information about anatomical localisation and morphology of tumours from very early
stages (<1 mm diameter).
Beyond the specific study of the biodistribution and tumour development of an exemplary mes-
enchymal cell line performed here, we emphasise the technological potential of these labelling tools
for non-invasive in vivo imaging and cell tracking. In particular, research fields such as cell-based
regenerative medicine therapies and cancer biology might find new applications using these label-
ling reagents and imaging approaches for cell monitoring and safety studies.
Figure 7. Monitoring tumour growth over time. Tumour four in Figure 6 was chosen to demonstrate the potential of the MSOT approach in monitoring
tumour growth longitudinally over time. A small tumour was localised in the pelvic ilium region at day 13 and its growth was monitored from day 13 to
day 30. 3D reconstructions of the tumour are shown on the right panel (360˚ animations are available as Figure 7—video 1). Changes in size can be
determined with this technique. Colour scale is 0.4 to 15 MSOT intensity units (a.u.).
DOI: https://doi.org/10.7554/eLife.33140.019
The following video is available for figure 7:
Figure 7—video 1. 360˚ animation of the 3D reconstructions shown in Figure 7 of the main text.
DOI: https://doi.org/10.7554/eLife.33140.020
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Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
SCID hairless outbred
(SHO) mice
mice Charles River
Laboratories
ID_Crl:SHO-PrkdcscidHrhr
Mouse mesenchymal
stem cell line
mMSC ATCC ID_ATCC:CRL-12424
Continued on next page
Figure 8. Longitudinal tumour monitoring in a mouse that was injected with GNR-860/reporter gene labelled
cells. Localisation of tumours 40 days after systemic injection of cells imaged by bioluminescence (a) and MSOT
(b). (c) Growth of the tumour on the left shoulder was monitored from day 33 to day 40 and is shown in 3D
reconstruction. Colour scale in (a) is 1.4  108 to 1.3  109 radiance units (r  s 1  cm 2  sr 1) and in (b) is 1.2 to
14 MSOT intensity units (a.u.). The black pixels visible within the tumour region in (b) are an experimental artefact
(see Figure 8—figure supplement 1 for additional discussion).
DOI: https://doi.org/10.7554/eLife.33140.021
The following figure supplement is available for figure 8:
Figure supplement 1. Comparison of MSOT image reconstruction using software version 3.6 and 3.8.
DOI: https://doi.org/10.7554/eLife.33140.022
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
Lentivirus vector pHIV-iRFP720-E2A-Luc this paper ID_GenBank:MF693179;
ID_Addgene:104587
lentivirus vector for bi-cistronic
expression of iRFP720 and firefly
luciferase
Gold nanorods GNR this paper gold nanorods were produced at the
Department of Chemistry, University
of Liverpool
Reagents
The following chemicals were purchased from Sigma-Aldrich (Gillingham, UK). HAuCl4 3H2O
(>99.0%), NaBH4 (>99.99%), AgNO3(99.0%), hexadecyltrimethylammonium bromide (CTAB,>99%),
L-ascorbic acid (reagent grade), tetraethyl orthosilicate (TEOS, 99.999%), O-[2-(3-Mercaptopropiony-
lamino)ethyl]-O0-methylpolyethylene glycol (mPEG-SH, MW: 5000 Da), 5-bromosalicylic acid. Mono-
carboxy (1-mercaptoundec-11-yl) hexaethylene glycol (PEG-COOH, MW 526.73 Da) was obtained
from Prochimia (Sopot, Poland). Dulbecco’s modified eagle’s medium (DMEM), phosphate-buffered
saline (PBS), penicillin-streptomycin, biliverdin and polybrene were also obtained from Sigma
Aldrich. Foetal bovine serum (FBS) was purchased from Life-Technologies. D-Luciferin was purchased
from Promega (Southampton, UK) and CycLuc1 from Glixx Laboratories (Southborough, USA).
Gold nanorod synthesis
GNR synthesis were based on previously published protocols (Nikoobakht and El-Sayed, 2003;
Ye et al., 2012). First, seeds were prepared by adding 0.6 mL of ice-cold NaBH4 (0.01 M) to a mix-
ture of 5 mL CTAB (0.2 M) and 5 mL of HAuCl4 (0.5 mM) under vigorous stirring. The growth solution
for GNR-710 was prepared by mixing 50 mL of CTAB (0.2M), 1.8 mL of AgNO3 (4 mM), 50 mL of
HAuCl4 (1 mM) and 0.8 mL of ascorbic acid (0.1 M). Finally, 0.2 mL of freshly synthesised seeds was
added to the growth solution. The reaction was kept in a water bath at 28˚C for 3 hr. The growth
solution for GNR-860 was prepared by adding 440 mg of 5-bromosalicylic acid to 100 mL of CTAB
(0.1 M) and heat up the mixture to 60˚C. After cooling down the solution to 30˚C, 4.8 mL of AgNO3
(4 mM) was added and left undisturbed for 15 min. Then, 50 mL of HAuCl4 (1 mM) was added and
left under low stirring for 15 min at 30˚C. Afterwards, 256 mL of ascorbic acid was added under vig-
orous agitation for 30 s. Finally, 160 mL of seeds were added and the solution was kept at 28˚C for
12 hr. Silica coating was performed as described in our previous work (Comenge et al., 2016), which
was based on slight modifications of a protocol by Ferna´ndez-Lo´pez et al (Ferna´ndez-Lo´pez et al.,
2009).
GNRs were visualized using a Tecnai G3 Spirit transmission electron microscope (TEM) at 120
keV. Formvar/carbon-coated 200 mesh copper grid (TAAB) were dipped in a solution of the GNRs
of interest and left to dry in air. More than 100 GNRs were considered for image analysis.
Lentivirus vectors
Lentivirus vectors were constructed on the pHIV-Luciferase backbone (a gift from Bryan Welm,
Addgene plasmid # 21375). The iRFP720 ORF was obtained from plasmid piRFP720-N1 (a gift from
Vladislav Verkhusha, Addgene plasmid # 45461) (Shcherbakova and Verkhusha, 2013) and cloned
as an EcoRI/XbaI fragment upstream of the IRES element of pHIV-Luciferase, resulting in the pHIV-
iRFP720-IRES-Luc vector. To achieve a more efficient translation of the second ORF, the IRES ele-
ment was replaced with an E2A peptide motif (Szymczak and Vignali, 2005; Szymczak et al.,
2004) using a two-step PCR protocol to create the pHIV-iRFP720-E2A-Luc plasmid. The complete
sequence of the E2A plasmid version has been submitted to the NCBI GenBank database (accession
number: MF693179). Lentivirus particles were produced in HEK293T cells, which were purchased for
this work from ATCC (ATCC CRL-3216) and free of mycoplasma when tested with the e-Myco Myco-
plasma PCR Detection Kit (iNtRON Biotechnology, cat. no. 25235). Cells were transfected via cal-
cium phosphate co-transfection of the reporter gene plasmid, packaging plasmid psPAX2 and
envelope plasmid pMD2.G (both a gift of Didier Trono, Addgene plasmids #12260 and #12259,
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respectively) as described (Kutner et al., 2009). Virus-containing cell culture supernatant was col-
lected three days post-transfection, centrifuged at 500 g and filtered through 0.45 mm pores.
Mouse mesenchymal stem/stromal cell (mMSC) line culture, labelling
and immunofluorescence
We chose the mouse MSC line D1 ORL UVA [D1](ATCC CRL-12424) for labelling and tracking, since
these cells have the potential to differentiate into mesenchymal derivatives, but can occasionally also
form tumours as previously shown (Comenge et al., 2016; Kuzma-Kuzniarska et al., 2012). The
mMSC cell line was purchased for this work from ATCC and free of mycoplasma when tested with
the e-Myco Mycoplasma PCR Detection Kit (iNtRON Biotechnology, cat. no. 25235). Furthermore,
the mMSC cells were re-authenticated by Science Exchange – IDEXX BioResearch using short tan-
dem repeat (STR) profiling. They were found to be of mouse origin and no other mammalian inter-
species contamination was detected. They were grown in DMEM supplemented with 10% FBS and 2
mM L-Glutamine. Cells were transfected with purified reporter gene virus particles for 24 hr.
iRFP720-expressing cells were sorted using a BD FACSAria III with red laser and APC-CyTM7 filter.
Cells expressing high levels of iRFP720 were selected and maintained for all further experiments.
Before IVIS imaging of cells, biliverdin was added to the culture medium for 24 hr to increase its con-
centration beyond levels present in FBS and to improve its uptake by cells for incorporation into
iRFP720 as a chromophore. For analysis of reporter gene expression by immunofluorescence,
mMSCs were grown on glass cover slips, fixed with 4% paraformaldehyde/PBS, washed with PBS,
blocked and stained with an anti-firefly luciferase antibody (Abcam, Cambridge, UK, ab21176,
diluted in 1:500 in PBS/10% donkey serum/0.25% Triton-X100) and a donkey-anti-rabbit-Alexa-
Fluor488 secondary antibody (Molecular Probes, A21206). Fluorescence of iRFP720 was assessed
directly using a Zeiss LSM510 Multiphoton microscope.
GNR-labelling was performed as previously published (Comenge et al., 2016). Briefly, cells were
treated with cell medium containing GNRs at the concentration/optical density indicated in the
Results (always 79% cell medium, 20% GNRs in water, 1% penicillin-streptomycin). Unless otherwise
stated, cells were labelled to a GNR O.D. = 3.0. Then, cells were dissociated with trypsin, resus-
pended in fresh medium, washed twice with PBS, and counted using an automated cell counter
(TC10, BioRad, Watford, UK).
Cell viability
Cell viability was assessed with Cell Titer Glo ATP Assay (Promega). Cells were labelled as described
above by seeding 104 mMSCs cells in 96-well plates. Cells were incubated with GNRs-710 and GNR-
860 at a final O.D. in media = 1, 2, 3.2, and 4 (80% media and 20% GNRs solution in each case) for
24 hr. After labelling, cells were washed three times with PBS. 50 mL of medium were added to each
well and then 25 mL of the ATP reagent was added. The plate was mixed in an orbital shaker and,
after 10 min, the contents of the plate were transferred to white, opaque, 96-well plates and the
luminescence measured with a plate reader (Fluostar Omega, BMG Labtech, Aylesbury, UK). Each
condition was assessed in triplicate and results are given as %±SD relative to cells that were incu-
bated without GNRs as described above.
Preparation of cells for TEM
Cells were fixed with a solution containing 1% paraformaldehyde and 3% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.4). Then, cells were incubated with a reduced osmium staining solution, con-
taining 2% OsO4 and 1.5% K4[Fe(CN)6], for 1 hr. This was followed by a second 1 hr osmium staining
(2% OsO4) step and overnight staining with 1% uranyl acetate. Cells were washed with water for 3
min, three times after every staining step. Samples were then dehydrated in graded ethanol (30%,
50%, 70%, 90% and 2  100%) for 5 min each. Finally, samples were infiltrated with medium TAAB
resin 812 and embedded within the same resin. The resin was cured for 48 hr at 60˚C. Finally, ultra-
thin sections of 350 mm x 350 mm x 74 nm were cut and placed in 200-mesh Formvar/Carbon filmed
grids. They were post-stained with uranyl acetate (4% UA in a 50:50 ethanol/water solution) and Rey-
nolds lead citrate before TEM imaging.
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Animals
8–10 week-old female SCID hairless outbred (SHO) mice (Charles River, Margate, UK) were housed
in individually ventilated cages at a 12 hr light/dark cycle, with ad libitum access to food and water.
Experimental animal protocols were performed in accordance with the guidelines under the Animals
(Scientific Procedures) Act 1986 (licence PPL70/8741) and approved by the University of Liverpool
Animal Welfare and Ethical Review Body. The tumour burden was monitored and kept within recom-
mended limits in accordance with guidelines for the welfare and use of animals in cancer research
(Workman et al., 2010). Experiments are reported in line with the ARRIVE guidelines. These experi-
ments aimed at evaluating the potential of MSOT to track cells over the short and long-term. The
number of animals was chosen so that a range of tumour positions and sizes could be observed
(Table 1). Image quantification is presented to demonstrate the information that can be extracted
from this approach. In each case, the numbers correspond to the particular animal presented. The
data for these exemplar animals as well as for the other animals are available in the data repository
Zenodo (Comenge et al., 2017).
Intracardiac injection and imaging
Transfected cells were labelled with GNR-710 and GNR-860 at O.D. = 2.4 as detailed above. 1.5 
106 cells in 100 mL PBS were prepared for intracardiac injection as described below. All cell injection
and imaging procedures of mice were carried out under general isoflurane/oxygen anaesthesia.
The imaging routine at day 0 was composed of the following sequence of steps: 1) a baseline
MSOT scan; 2) the ultrasound-guided (Prospect imaging system, S-Sharp, New Taipei City, Taiwan)
intracardiac injection of cells into the left ventricle; 3) a second MSOT scan after 10 min for acclimati-
sation; 4) BLI, for which the mouse received an intraperitoneal injection of D-luciferin (approximately
150 mg/g body weight) 15 min before whole body imaging using an IVIS Spectrum system (Perkin
Elmer, Seer Green, UK). All data were analysed with Living Image (Perkin Elmer) and data are dis-
played in radiance units. On subsequent days, the MSOT scan and BLI were repeated in the same
manner.
For intracardiac injection of cells, mice were positioned supine on a heated platform. Fur around
the chest area was removed using depilatory cream and limbs were taped down to keep the mouse
position fixed. Ultrasound gel was applied liberally to the chest area and the ultrasound transducer
(Prospect imaging system, S-Sharp) was positioned above the chest so the long axis view of the left
ventricle was visible. 100 ml of cell suspension was drawn up into an insulin syringe (29 G) and, using
the ultrasound image as guidance, was inserted into the left ventricle of the heart. Cell suspension
was then administered slowly over a period of approximately 30 s.
For optoacoustic imaging, an MSOT inVision 256-TF small animal imaging system (iThera Medical
GmbH, Munich, Germany) was used (Morscher et al., 2014). After acclimatisation for 10 min inside
the water bath, a whole-body scan was performed on the mouse with 1 mm steps and the following
wavelengths for acquisition: 660, 670, 680, 690, 700, 705, 710, 715, 720, 725, 735, 750, 765, 780,
795, 810, 820, 830, 840, 850, 860, 870, 880, 890, 900, 910, 920, 930, 940, 1025, 1050, 1075, and
1100 nm. Heavy water was used in the water bath due to its low absorbance at wavelengths > 910
nm (contrary to regular water). Linear-mode-based reconstruction and guided ICA multispectral
processing were applied using viewMSOT software v3.6 (iThera Medical GmbH).
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